GlassScriptPhysician profile
Erik C Hustak
NPI 1558520668
$6,385.75
in general payments reported to CMS, 2019-2025
23 companies · $808 in 2025
The $808 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $50.84 · 2021: $382 · 2022: $676 · 2023: $3,546 · 2024: $725 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,852 · Food and Beverage: $2,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,852.36 |
| Food and Beverage | $2,226.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,115.21 | 2021-2025 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $1,484.26 | 2022-2023 | Intracept |
| Abbvie INC. | $574.96 | 2022-2025 | |
| Boston Scientific Corporation | $442.91 | 2019-2025 | General - Pain Management, Intracept |
| Abbott Laboratories | $397.15 | 2023-2025 | Proclaim, Eterna |
| Painteq LLC | $192.80 | 2022-2024 | Painteq |
| Vertos Medical, INC. | $176.06 | 2021-2024 | Mild Device Kit |
| Davol INC. | $168.41 | 2022 | |
| Nevro Corp. | $159.84 | 2021 | |
| Saluda Medical Americas, INC. | $125.00 | 2025 | Evoke |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Flowonix Medical Incorporated | $83.36 | 2019 | |
| Allergan, INC. | $59.83 | 2020-2022 | |
| Medtronic USA, INC. | $52.39 | 2019 | |
| Spr Therapeutics, INC | $50.76 | 2025 | Sprint Pns System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $35.75 | 2023 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $32.06 | 2025 | |
| Biodelivery Sciences International, INC. | $28.80 | 2021 | |
| Globus Medical, INC. | $28.59 | 2025 | Senza |
| Tersera Therapeutics LLC | $25.75 | 2024 | Prialt |
| Takeda Pharmaceuticals U.S.A., INC. | $24.35 | 2025 | Livtencity |
| Collegium Pharmaceutical, INC. | $15.06 | 2024 | Belbuca |
| Pfizer INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Hustak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.